CytoMed Therapeutics (GDTC) Q4 2023 Earnings
GDTC·Reported May 6, 2024·Before market open
CytoMed Therapeutics reported Q4 2023 revenue of $64.0K. Diluted EPS came in at $-0.05.
Revenue
$64.0K
Diluted EPS
$-0.05
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2023 Earnings FAQ
Common questions about CytoMed Therapeutics's Q4 2023 earnings report.
CytoMed Therapeutics (GDTC) reported Q4 2023 earnings on May 6, 2024 before market open.
CytoMed Therapeutics reported revenue of $64.0K and diluted EPS of $-0.05 for Q4 2023.